Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant TherapyVanessa Roldán, Gregory Y.H. Lip, Vicente Vicente et al.|CHEST Journal|2012Cited by 195
The HAS-BLED Score Has Better Prediction Accuracy for Major Bleeding Than CHADS2 or CHA2DS2-VASc Scores in Anticoagulated Patients With Atrial FibrillationVanessa Roldán, Gregory Y.H. Lip, Francisco Marı́n et al.|Journal of the American College of Cardiology|2013Cited by 190
Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillationPilar Gallego, Gregory Y.H. Lip, Vanessa Roldán et al.|Thrombosis and Haemostasis|2013Cited by 188
Relation of the HAS-BLED Bleeding Risk Score to Major Bleeding, Cardiovascular Events, and Mortality in Anticoagulated Patients With Atrial FibrillationPilar Gallego, Gregory Y.H. Lip, Vanessa Roldán et al.|Circulation Arrhythmia and Electrophysiology|2012Cited by 148
Plasma von Willebrand Factor Levels Are an Independent Risk Factor for Adverse Events Including Mortality and Major Bleeding in Anticoagulated Atrial Fibrillation PatientsVanessa Roldán, Gregory Y.H. Lip, Francisco Marı́n et al.|Journal of the American College of Cardiology|2011Cited by 132